what science?

There’s no scientific evidence, but AYUSH ministry is recommending alternative medicines for dengue

Allopathic doctors point out that there are no long-term studies to prove the efficiency of disciplines like siddha or unan.

Over the past fortnight, the Ministry of AYUSH has released a series of health advisories recommending alternative medicines to be taken to prevent dengue and chikungunya

infections as well as others to be taken with the onset of symptoms such as fever and joint pains. But doctors have criticised this step, saying that that the government is promoting self-medication of treatments that have little scientific basis.

The AYUSH ministry aims to ensure the development and spread of ayurveda, yoga and naturopathy, unani, siddha and homoeopathy. The department has five councils under its purview, one for each of these traditional systems of treatment.

Allopathic doctors do not believe that the ministry should be issuing advisories this way. “Health advisories should focus on broader prevention strategies and not prescribe treatments,” said Dr Anant Bhan, a researcher on global health and policy. “What if someone gets confused and takes all forms of prophylaxis advised by different councils. There could be side-effects.”

Previous initiatives

This is not the the first time that government authorities have recommended alternative medicine for viral fever outbreaks. Since 2013, the Tamil Nadu health and AYUSH departments have been providing a prophylaxis treatment to communities affected by dengue and chikungunya with a herbal siddha drug called Nilavembu kudineer. “The drug has been proved for its anti-inflammatory and analgesic effects,” claimed Dr P Sathiya Rajeswaran, assistant director, Central Council for Research in Siddha who helps run the dengue control programme in the state. “This drug is also effective in preventing swine flu and leptospirosis.”

This time, the Central Council for Research in Siddha has issued an advisory mentioning the name of medications to be taken for prevention of chikungunya. It also prescribes six different types of siddha medicines for fever and joint-pain management along with the exact dosage and duration. These medicines have already been approved by the AYUSH ministry and are being sold in India.

Rajeswaran said that the drug has distributed among the general population and no adverse events have been reported so far. However, he also said that there have been no clinical trials to test the efficacy and safety of the medicines but are recommending the Siddha treatment based on references in Siddha literature.

Advice without evidence

Franklin L Khobung, director of AYUSH, explained that this year’s advisories were issued as a measure to counter the recent surge in chikungunya and dengue cases. According to the National Vector Borne Disease Control Programme, more than 22,000 of suspected chikungunya cases were reported across the country between January and August 20. At the same time, 36,000 cases of dengue were recorded.

Asked if the advisories were a strategy to popularise these traditional forms of medicine, Khobung insisted that the government wants to give citizens different choices of treatment. “We want people to know that these forms of medicine exist and they have been recommended only after their validity is proven,” he said.

However, Khobung refused to reveal details on the studies and research that the ministry of AYUSH has conducted before recommending names of medicines which can prevent and treat mosquito borne diseases including chikungunya and dengue.

To understand the quality of their research, Scroll.in contacted representatives of the research councils under the AYUSH ministry. These councils have issued the advisories but interviews with the heads of the councils did not indicate that there is a satisfactory basis for the department’s recommendations.

Professor KS Dhiman, director general of Central Council for Research in Ayurvedic Sciences said that symptoms exhibited in chikungunya are similar to medical conditions defined in the Ayurvedic textbooks that used for bachelor’s courses in Ayurvedic Medicine and Surgery. “The clinical picture of chikungunya resembles another medical condition described in the ayurvedic textbooks,” said Dhiman. “Hence, we have prescribed the time-tested ayurveda drugs for chikungunya in the advisory.”

Dhiman did not cite any research for the advisory recommendations.

Similarly, Dr RK Manchanda, director general of the Central Council for Research in Homeopathy said that the advisory is based on “traditional knowledge” gathered over centuries. “These medicines mentioned in the advisory have been found to be useful in preventing dengue and chikungunya,” he said.

Where are the clinical trials?

Manchanda said that there are no “vaccine-trial like studies conducted” but there was an expert group that framed the advisories. “I cannot disclose the names of the institutes but there are several research studies going on.”

Manchanda added that the department felt the need to name the medicines in the advisory to ensure that practitioners of ayurveda also prescribe the drugs that the government is recommending. He referred to an editorial he has authored in the Indian Journal of Research in Homeopathy for the basis of the recommendations. In the editorial, however, he simply makes a case for more rigorous studies to be conducted on the use of homeopathy for the treatment of dengue. Manchanda quotes several studies from around the world, which by his own admission in the article, “had some or the other limitations ranging from small sample size, poor research design or abrupt withdrawal of study”. Nonetheless, he concluded: “...the data are sufficient to invoke more studies with better methodology and compliance.”

There is a heated debate globally about the efficacy of alternative forms of medicine. For example, studies have highlighted the presence of toxic heavy metals in Ayurvedic medicines. Allopathic doctors have publicly argued that the treatments administered by these disciplines are not efficient. “We have to ask [the AYUSH ministry] on what evidence are they relying on for promoting these treatments,” said Dr Jayesh Lele, state secretary of Maharashtra’s Indian Medical Association. “These are old sciences and the medical conditions they are claiming to prevent through these prophylaxis doses are relatively new. How did they gather evidence?”

Drugs used in modern medicine must clear clinical trials for efficacy and safety before getting marketing approval. The larger problem with the government’s recommendation of alternative medicine is the lack of clinical data.

“We need a neutral body that looks at the data and studies,” said Bhan. “The problem here is that these advisories are directly coming from the government.”

The government’s health advisories suggest that people with symptoms of viral fever take the alternative medicines listed under the supervision of a registered doctor. However, a senior doctor from Mumbai said that by listing the names of alternative medicines the AYUSH Ministry is encouraging people to medicate themselves. “If a patient takes these medicines and his condition deteriorates and there is delay in seeking treatment, then who will be responsible?” he asked. “Already in India, people self-medicate, such an irresponsible step on the part of the government will make matters worse.”

We welcome your comments at letters@scroll.in.
Sponsored Content BY 

Relying on the power of habits to solve India’s mammoth sanitation problem

Adopting three simple habits can help maximise the benefits of existing sanitation infrastructure.

India’s sanitation problem is well documented – the country was recently declared as having the highest number of people living without basic sanitation facilities. Sanitation encompasses all conditions relating to public health - especially sewage disposal and access to clean drinking water. Due to associated losses in productivity caused by sickness, increased healthcare costs and increased mortality, India recorded a loss of 5.2% of its GDP to poor sanitation in 2015. As tremendous as the economic losses are, the on-ground, human consequences of poor sanitation are grim - about one in 10 deaths, according to the World Bank.

Poor sanitation contributes to about 10% of the world’s disease burden and is linked to even those diseases that may not present any correlation at first. For example, while lack of nutrition is a direct cause of anaemia, poor sanitation can contribute to the problem by causing intestinal diseases which prevent people from absorbing nutrition from their food. In fact, a study found a correlation between improved sanitation and reduced prevalence of anaemia in 14 Indian states. Diarrhoeal diseases, the most well-known consequence of poor sanitation, are the third largest cause of child mortality in India. They are also linked to undernutrition and stunting in children - 38% of Indian children exhibit stunted growth. Improved sanitation can also help reduce prevalence of neglected tropical diseases (NTDs). Though not a cause of high mortality rate, NTDs impair physical and cognitive development, contribute to mother and child illness and death and affect overall productivity. NTDs caused by parasitic worms - such as hookworms, whipworms etc. - infect millions every year and spread through open defecation. Improving toilet access and access to clean drinking water can significantly boost disease control programmes for diarrhoea, NTDs and other correlated conditions.

Unfortunately, with about 732 million people who have no access to toilets, India currently accounts for more than half of the world population that defecates in the open. India also accounts for the largest rural population living without access to clean water. Only 16% of India’s rural population is currently served by piped water.

However, there is cause for optimism. In the three years of Swachh Bharat Abhiyan, the country’s sanitation coverage has risen from 39% to 65% and eight states and Union Territories have been declared open defecation free. But lasting change cannot be ensured by the proliferation of sanitation infrastructure alone. Ensuring the usage of toilets is as important as building them, more so due to the cultural preference for open defecation in rural India.

According to the World Bank, hygiene promotion is essential to realise the potential of infrastructure investments in sanitation. Behavioural intervention is most successful when it targets few behaviours with the most potential for impact. An area of public health where behavioural training has made an impact is WASH - water, sanitation and hygiene - a key issue of UN Sustainable Development Goal 6. Compliance to WASH practices has the potential to reduce illness and death, poverty and improve overall socio-economic development. The UN has even marked observance days for each - World Water Day for water (22 March), World Toilet Day for sanitation (19 November) and Global Handwashing Day for hygiene (15 October).

At its simplest, the benefits of WASH can be availed through three simple habits that safeguard against disease - washing hands before eating, drinking clean water and using a clean toilet. Handwashing and use of toilets are some of the most important behavioural interventions that keep diarrhoeal diseases from spreading, while clean drinking water is essential to prevent water-borne diseases and adverse health effects of toxic contaminants. In India, Hindustan Unilever Limited launched the Swachh Aadat Swachh Bharat initiative, a WASH behaviour change programme, to complement the Swachh Bharat Abhiyan. Through its on-ground behaviour change model, SASB seeks to promote the three basic WASH habits to create long-lasting personal hygiene compliance among the populations it serves.

This touching film made as a part of SASB’s awareness campaign shows how lack of knowledge of basic hygiene practices means children miss out on developmental milestones due to preventable diseases.

Play

SASB created the Swachhata curriculum, a textbook to encourage adoption of personal hygiene among school going children. It makes use of conceptual learning to teach primary school students about cleanliness, germs and clean habits in an engaging manner. Swachh Basti is an extensive urban outreach programme for sensitising urban slum residents about WASH habits through demos, skits and etc. in partnership with key local stakeholders such as doctors, anganwadi workers and support groups. In Ghatkopar, Mumbai, HUL built the first-of-its-kind Suvidha Centre - an urban water, hygiene and sanitation community centre. It provides toilets, handwashing and shower facilities, safe drinking water and state-of-the-art laundry operations at an affordable cost to about 1,500 residents of the area.

HUL’s factory workers also act as Swachhata Doots, or messengers of change who teach the three habits of WASH in their own villages. This mobile-led rural behaviour change communication model also provides a volunteering opportunity to those who are busy but wish to make a difference. A toolkit especially designed for this purpose helps volunteers approach, explain and teach people in their immediate vicinity - their drivers, cooks, domestic helps etc. - about the three simple habits for better hygiene. This helps cast the net of awareness wider as regular interaction is conducive to habit formation. To learn more about their volunteering programme, click here. To learn more about the Swachh Aadat Swachh Bharat initiative, click here.

This article was produced by the Scroll marketing team on behalf of Hindustan Unilever and not by the Scroll editorial team.